Latest Content

Minimally invasive thymectomy for ocular myasthenia gravis (MG) enhanced complete stable remission rates and reduced surgical risks.

Experts met in Park City, Utah, on October 7, 2025, to discuss how new technologies can help address chronic kidney disease.

A phase 3 trial shows lumateperone added to antidepressant therapy delivers greater symptom improvement and maintains a favorable safety profile in adults with MDD.

ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.

Patients with stage I to IIIA NSCLC had lower 2- and 4-year mortality in states that expanded Medicaid coverage.

As open enrollment continues, 77% of surveyed Americans were happy with their options for 2026 health care coverage, although cost concerns surfaced.

Polarized dermatoscopes produced higher-quality teledermatology images but at greater cost, raising questions about feasibility and equitable access.

A study finds no increased risk of arterial dissections or aneurysms among patients with metastatic colorectal cancer treated with angiogenesis inhibitors.

A national survey shows high overall trust in scientists, but confidence declines steadily with political conservatism.